Motif neurotech - About the company
Motif neurotech is a series A company based in Houston (United States), founded in 2022 by Jacob Robinson. It operates as a Developer of minimally invasive bioelectronics for mental health disorders. Motif neurotech has raised $18.8M in funding from Arboretum Ventures, with a current valuation of $*****. The company has 49 active competitors, including 10 funded and 4 that have exited. Its top competitors include companies like NeuroSigma, Spark Biomedical and Freespira.
Company Details
Developer of minimally invasive bioelectronics for mental health disorders. It offers a miniature brain pacemaker that stimulate the brain to restore healthy circuit activity and treat mental health disorders like treatment resistant depression.
- Website
- motifneuro.tech
- Email ID
- *****@motifneuro.tech
Key Metrics
Founded Year
2022
Location
Houston, United States
Stage
Series A
Total Funding
$18.8M in 1 round
Latest Funding Round
Post Money Valuation
$***** as on May 11, 2020
Investors
Ranked
1st among 49 active competitors
Employee Count
34 as on Sep 30, 2026
Similar Companies
Sign up to download Motif neurotech's company profile
Motif neurotech's funding and investors
Motif neurotech has raised a total funding of $18.8M over 1 round. Its latest funding round was a Series A round on Jan 24, 2024 for $*****. 11 investors participated in its latest round. Motif neurotech has 10 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of Motif neurotech:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 24, 2024 | 5495386 | Series A | 9134367 | 1350808 | 9836671 | 7650017 |
Access funding benchmarks and valuations. Sign up today!View details of Motif neurotech's funding rounds and investors
Motif neurotech's founders and board of directors
Founder? Claim ProfileThe founders of Motif neurotech is Jacob Robinson. Jacob Robinson is the CEO of Motif neurotech.
Here are the details of Motif neurotech's key team members:
- Jacob Robinson: Co-Founder & CEO of Motif neurotech. Contact Info: 1 email address
View details of Motif neurotech's Founder profiles and Board Members
Motif neurotech's employee count trend
Motif neurotech has 34 employees as of Sep 26. Here is Motif neurotech's employee count trend over the years:
Uncover Motif neurotech's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Motif neurotech's Competitors and alternates
Top competitors of Motif neurotech include NeuroSigma, Spark Biomedical and Freespira. Here is the list of Top 10 competitors of Motif neurotech, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Motif neurotech 2022, Houston (United States), Series A | Developer of minimally invasive bioelectronics for mental health disorders | $18.8M | 60/100 | |
2nd | NeuroSigma 2008, Los Angeles (United States), Seed | Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders | $2.92M | 58/100 | |
3rd | Spark Biomedical 2018, Houston (United States), Series A | Developer of wearable neurostimulation technology for drug-free opioid withdrawal treatment | $31.2M | 57/100 | |
4th |  Freespira 2008, Danville (United States), Series D | Medical device & Mobile app to treat panic disorders | $48.9M | 56/100 | |
5th | Nexalin 2010, Tustin (United States), Public | A non-invasive and drug free treatment for the treatment of anxiety, depression and insomnia | $502K | - | 49/100 |
6th | Cervel 2008, Redwood City (United States), Acquired | Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression | $23.6M | 47/100 | |
7th | Developer of a non-invasive therapeutic approach using ultrasound neuromodulation | $25.8M | 46/100 | ||
8th |  Neuroelectrics 2011, Barcelona (Spain), Series A | Provider of wireless EEG monitoring and brain stimulation devices | $17.9M | 41/100 | |
9th |  Inner Cosmos 2017, Portola Valley (United States), Seed | Provider of AI-based device for treating mood and addiction disorders | $11.9M | 41/100 | |
10th | Rio Grande Neurosciences 2011, San Francisco (United States), Series A | Non-invasive brain stimulation therapies | $8.93M | - | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Motif neurotech's competitors? Click here to see the top ones
Motif neurotech's Investments and acquisitions
Motif neurotech has made no investments or acquisitions yet.
Reports related to Motif neurotech
Here is the latest report on Motif neurotech's sector:
News related to Motif neurotech
Media has covered Motif neurotech for a total of 4 events in the last 1 year, 2 of them have been about company updates and 1 about partnerships.
•
MintNeuro and Motif Neurotech Partner on Miniaturized Brain-Computer Interface TherapiesNew Electronics•May 01, 2026•MintNeuro, Motif neurotech
•
Motif Neurotech Receives FDA Approval to Begin First Clinical Trial of its Therapeutic BCI for Treatment-Resistant DepressionBusiness Wire•Apr 27, 2026•Motif neurotech
•
Motif Neurotech Launches Patient Registry for Future Research OpportunitiesBusiness Wire•Dec 16, 2025•Motif neurotech
•
Motif Neurotech Secures UK Government Funding to Develop Brain-Computer Interface for Cognitive and Psychiatric ConditionsG-MedTech•Jan 21, 2025•Motif neurotech
•
Motif Neurotech has filed a notice of an exempt offering of securities to raise $21,554,201.00 in New Equity Investment.https://www.intelligence360.news/•Jan 31, 2024•Motif neurotech
•
Motif Neurotech Raises $18.75 Million in Series A Financing to Advance Implantable Device for Treatment-Resistant DepressionBusiness Wire•Jan 24, 2024•Arboretum Ventures, Motif neurotech, KdT Ventures, Satori Capital and 10 others
•
Motif Neurotech Conducts First-In-Human Brain Stimulation for Treatment-resistant DepressionHIT Consultant•Sep 22, 2023•Motif neurotech, medRxiv
•
Motif Neurotech Strengthens Leadership Team with Appointment of Steven Goetz as Chief Technology OfficerBusiness Wire•Jul 24, 2023•Motif neurotech, Medtronic
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Motif neurotech
Explore our recently published companies
- AMPIN Energy Transition - India based, 2023 founded, Unfunded company
- ZSU Webdesign - Hungary based, Unfunded company
- Zuka - United Arab Emirates based, Unfunded company
- Zogglar - Brazil based, 2006 founded, Unfunded company
- Zimmerei Menz - Wenzlow based, Unfunded company
- Zenovation Group - Unfunded company
